FSMDX
Price
$35.59
Change
+$0.18 (+0.51%)
Updated
Jul 16 closing price
Net Assets
42.38B
HEQCX
Price
$5.52
Change
+$0.02 (+0.36%)
Updated
Jul 16 closing price
Net Assets
14.9M
Interact to see
Advertisement

FSMDX vs HEQCX

Header iconFSMDX vs HEQCX Comparison
Open Charts FSMDX vs HEQCXBanner chart's image
Fidelity Mid Cap Index
Price$35.59
Change+$0.18 (+0.51%)
VolumeN/A
Net Assets42.38B
Monteagle Opportunity Equity Instl
Price$5.52
Change+$0.02 (+0.36%)
VolumeN/A
Net Assets14.9M
FSMDX vs HEQCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FSMDX vs. HEQCX commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMDX is a Buy and HEQCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMDX has more cash in the bank: 42.4B vs. HEQCX (14.9M). HEQCX pays higher dividends than FSMDX: HEQCX (7.25) vs FSMDX (1.31). FSMDX was incepted earlier than HEQCX: FSMDX (14 years) vs HEQCX (14 years). HEQCX (1.31) is less costly to investors than FSMDX (0.03). HEQCX is a more actively managed with annual turnover of: 54.00 vs. FSMDX (15.00). FSMDX has a lower initial minimum investment than HEQCX: FSMDX (0) vs HEQCX (1000000). FSMDX annual gain was more profitable for investors over the last year : 8.58 vs. HEQCX (6.79). FSMDX return over 5 years is better than : 70.17 vs. HEQCX (9.80).
FSMDXHEQCXFSMDX / HEQCX
Total Expense Ratio0.031.312%
Annual Report Gross Expense Ratio0.031.312%
Fund Existence14 years14 years-
Gain YTD5.1112.558200%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets42.4B14.9M284,564%
Annual Yield % from dividends1.317.2518%
Returns for 1 year8.586.79126%
Returns for 3 years45.924.531,013%
Returns for 5 years70.179.80716%
Returns for 10 years117.56-36.96-318%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GROV1.510.08
+5.59%
Grove Collaborative Holdings
ANIK11.190.19
+1.73%
Anika Therapeutics
COMP6.580.10
+1.54%
Compass
BWA35.170.18
+0.51%
BorgWarner
ABLLL24.75-0.04
-0.16%
Abacus Global Management Inc. 9.875% Fixed Rate Senior Notes due 2028